SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-07-015545
Filing Date
2007-03-01
Accepted
2007-03-01 16:20:58
Documents
10
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a07-3650_110k.htm 10-K 2809046
2 EX-10.42 a07-3650_1ex10d42.htm EX-10.42 3491
3 EX-10.43 a07-3650_1ex10d43.htm EX-10.43 17868
4 EX-21.1 a07-3650_1ex21d1.htm EX-21.1 4294
5 EX-23.1 a07-3650_1ex23d1.htm EX-23.1 2391
6 EX-23.2 a07-3650_1ex23d2.htm EX-23.2 2123
7 EX-31.1 a07-3650_1ex31d1.htm EX-31.1 9298
8 EX-31.2 a07-3650_1ex31d2.htm EX-31.2 9081
9 EX-32.1 a07-3650_1ex32d1.htm EX-32.1 5749
10 GRAPHIC g36501doi001.gif GRAPHIC 10645
  Complete submission text file 0001104659-07-015545.txt   2879455
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19319 | Film No.: 07663652
SIC: 2834 Pharmaceutical Preparations